← Browse by Condition
Medical Condition

metastatic clear cell renal cell carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT07179770 Phase 1
Recruiting

Effects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC)

Enrollment
12 pts
Location
United States
Sponsor
NYU Langone Health
View Trial →